We are live on ! Find out more
CRDF icon

Cardiff Oncology
CRDF

60 hedge funds and large institutions have $10.7M invested in Cardiff Oncology in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 9 increasing their positions, 14 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 10

3% more funds holding

Funds holding: 58 → 60 (+2)

1.06% less ownership

Funds ownership: 18.29% → 17.23% (-1.1%)

12% less capital invested

Capital invested by funds: $12.2M → $10.7M (-$1.48M)

36% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 14

93% less call options, than puts

Call options by funds: $5K | Put options by funds: $75K

Holders
60
Holders Change
+2
Holders Change %
+3.45%
% of All Funds
0.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
9
Reduced
14
Closed
10
Calls
$5K
Puts
$75K
Net Calls
-$70K
Net Calls Change
-$117K

Top Buyers

1
GCP
GSA Capital Partners
United Kingdom
+$336K
2
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$141K
3
Renaissance Technologies
Renaissance Technologies
New York
+$98.8K
4
Two Sigma Investments
Two Sigma Investments
New York
+$33.4K
5
CC
Callan Capital
California
+$19.5K

Top Sellers

1
Citadel Advisors
Citadel Advisors
Florida
-$279K
2
Morgan Stanley
Morgan Stanley
New York
-$137K
3
Millennium Management
Millennium Management
New York
-$84.5K
4
Bank of America
Bank of America
North Carolina
-$60.5K
5
CL
CSS LLC
Illinois
-$55K
Name Holding Trade Value Shares
Change 		Change in
Stake
US Bancorp
51
US Bancorp
Minnesota
$153 – – –
AF
52
Allworth Financial
California
$140 – – –
Citigroup
53
Citigroup
New York
$140 +$143 +100 New
Northwestern Mutual Wealth Management
54
Northwestern Mutual Wealth Management
Wisconsin
$67 – – –
Dimensional Fund Advisors
55
Dimensional Fund Advisors
Texas
$44 -$12.7K -8,864 -22%
FGAM
56
Financial Gravity Asset Management
Texas
$2 +$1 +1 New
TFS
57
TrustCore Financial Services
Tennessee
$1 – – –
CL
58
CSS LLC
Illinois
– -$55K -35,920 Closed
Qube Research & Technologies (QRT)
59
Qube Research & Technologies (QRT)
United Kingdom
– -$46K -29,996 Closed
LPL Financial
60
LPL Financial
California
– -$40K -25,784 Closed
Jane Street
61
Jane Street
New York
– -$32K -20,461 Closed
Goldman Sachs
62
Goldman Sachs
New York
– -$22K -14,349 Closed
LP
63
LMR Partners
United Kingdom
– -$21K -13,584 Closed
Group One Trading
64
Group One Trading
Illinois
– -$6.62K -4,619 Closed
LTI
65
Laffer Tengler Investments
Tennessee
– -$32 -21 Closed
NA
66
NewEdge Advisors
Louisiana
– +$116 +81 New
TRCT
67
Tower Research Capital (TRC)
New York
– +$458 +320 New
1 2
3

CRDF Hedge Fund Activity: Q4 2022 in Review

60 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Cardiff Oncology (CRDF) for Q4 2022, worth a combined $10.7M — down 12% from $12.2M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new CRDF positions and 10 closed out — a net gain of 3 holders — while 9 added to existing stakes and 14 trimmed.

The largest buyer was GSA Capital Partners, adding an estimated $336K. The largest seller was Citadel Advisors, cutting an estimated $279K.

  • 60 institutional investors held Cardiff Oncology (CRDF) as of Q4 2022, up from 58 in Q3 2022.
  • Funds reported $10.7M of Cardiff Oncology stock for Q4 2022, down 12% quarter-over-quarter.
  • 13 funds opened new Cardiff Oncology positions in Q4 2022 and 10 closed out, a net change of +3 holders.
  • The largest Cardiff Oncology buyer in Q4 2022 was GSA Capital Partners, an estimated $336K added.
  • The largest Cardiff Oncology seller in Q4 2022 was Citadel Advisors, an estimated $279K sold.

Based on aggregated 13F filings for Q4 2022.